Author
Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.
5 papers
Recent·Most cited
T. Fleischer, M. H. Haugen, J. Ankill…·V. N. Kristensen
This study uses an integrated omics approach to show that DNA methylation at enhancer CpGs can predict response to neoadjuvant chemotherapy and bevacizumab in ER-positive patients.
M. R. Aure, T. Fleischer, S. Bjorklund…·V. N. Kristensen
The paper investigates how microRNA expression and DNA methylation interact to drive hormone-dependent breast cancer phenotypes by analyzing two breast cancer cohorts.
S. Gilfillan, S. Wang, M. R. Katika…·A. Hurtado-Rodriguez
This study shows that HER2/HER3 signaling and FOXA1 deacetylation drive ER-independent growth in hormone-resistant breast tumors by altering FOXA1 chromatin binding and function.
A. B. Brinkman, S. Nik-Zainal, F. Simmer…·H. G. Stunnenberg
The paper shows PMDs are hypervariable in breast cancer and drive CGI hypermethylation, but do not significantly repress cancer genes.
I. H. Rye, A. Trinh, A. Saetersdal…·H. G. Russnes
This study examines how intra-tumor heterogeneity in HER2 expression and copy number affects treatment outcomes in HER2+ breast cancer patients.